Yu MC - Search Results

1

Evidence of an X-linked or recessive genetic component to prostate cancer risk.

Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Monroe KR, et al. Among authors: yu mc. Nat Med. 1995 Aug;1(8):827-9. doi: 10.1038/nm0895-827. Nat Med. 1995. PMID: 7585188

2

Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

Reichardt JK, Makridakis N, Henderson BE, Yu MC, Pike MC, Ross RK. Reichardt JK, et al. Among authors: yu mc. Cancer Res. 1995 Sep 15;55(18):3973-5. Cancer Res. 1995. PMID: 7664265

3

The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

Irvine RA, Yu MC, Ross RK, Coetzee GA. Irvine RA, et al. Among authors: yu mc. Cancer Res. 1995 May 1;55(9):1937-40. Cancer Res. 1995. PMID: 7728763

4

Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.

Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. Yu MC, et al. J Natl Cancer Inst. 1994 May 4;86(9):712-6. doi: 10.1093/jnci/86.9.712. J Natl Cancer Inst. 1994. PMID: 8158701

5

Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.

Yu MC, Ross RK, Chan KK, Henderson BE, Skipper PL, Tannenbaum SR, Coetzee GA. Yu MC, et al. Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):861-4. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 8634658

6

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA. Ingles SA, et al. Among authors: yu mc. J Natl Cancer Inst. 1997 Jan 15;89(2):166-70. doi: 10.1093/jnci/89.2.166. J Natl Cancer Inst. 1997. PMID: 8998186

7

Genetic susceptibility to cancer from exogenous and endogenous exposures.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Feigelson HS, et al. Among authors: yu mc. J Cell Biochem Suppl. 1996;25:15-22. doi: 10.1002/(sici)1097-4644(1996)25+<15::aid-jcb2>3.0.co;2-5. J Cell Biochem Suppl. 1996. PMID: 9027593 Review.

8

Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk.

Devgan SA, Henderson BE, Yu MC, Shi CY, Pike MC, Ross RK, Reichardt JK. Devgan SA, et al. Among authors: yu mc. Prostate. 1997 Sep 15;33(1):9-12. doi: 10.1002/(sici)1097-0045(19970915)33:1<9::aid-pros2>3.0.co;2-h. Prostate. 1997. PMID: 9294620

9

Sex steroid hormones and genetic susceptibility to breast and prostate cancer.

Feigelson HS, Ross RK, Yu MC, Coetzee GA, Reichardt JK, Henderson BE. Feigelson HS, et al. Among authors: yu mc. Drug Metab Rev. 1998 May;30(2):421-34. doi: 10.3109/03602539808996320. Drug Metab Rev. 1998. PMID: 9606611 Review. No abstract available.

10

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN, Henderson BE. Ross RK, et al. Among authors: yu mc. Cancer Res. 1998 Oct 15;58(20):4497-504. Cancer Res. 1998. PMID: 9788589 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters